• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大规模分级分离方法的发展。VII. 抗凝血酶III浓缩物的制备。

Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate.

作者信息

Wickerhauser M, Williams C, Mercer J

出版信息

Vox Sang. 1979;36(5):281-93. doi: 10.1111/j.1423-0410.1979.tb04436.x.

DOI:10.1111/j.1423-0410.1979.tb04436.x
PMID:462917
Abstract

A large scale method for preparation of antithrombin III (AT III) concentrate from plasma or from Cohn fraction IV-1 (Fr. IV-1) has been described. It consists of the following steps: (a) partial purification by precipitation of impurities with 20% polyethylene glycol (PEG) 4000; (b) isolation of AT III from the PEG supernatant by batch adsorption and elution on heparin-Sepharose at a ratio corresponding to 45 vol of plasma or 80 vol of 10% Fr. IV-1 solution to 1 vol of gel; (c) concentration and desalting of the eluted AT III on a Pellicon ultrafiltration system; (d) pasteurization of AT III concentrate by heating for 10 h at 60 degrees C in the presence of 0.5 M sodium citrate at pH 7.5; (e) removal of excess citrate by gel filtration on Sephadex G-50; and (f) sterile filtration, filling and lyophilization. The recovery by activity was 32% from a 113-liter plasma batch and 16% from a 42-kg Fr. IV-1 batch. Both AT III concentrates, derived either from plasma or from Fr. IV-1, had similar specific activity and electrophoretic purity, were nonpyrogenic and met all other FDA requirements for biologic products. Pasteurization induced changes in disc gel and isotachophoretic patterns of AT III preparations.

摘要

已描述了一种从血浆或科恩IV-1组分(Fr.IV-1)制备抗凝血酶III(AT III)浓缩物的大规模方法。它包括以下步骤:(a)用20%聚乙二醇(PEG)4000沉淀杂质进行部分纯化;(b)通过在肝素-琼脂糖上进行批量吸附和洗脱,从PEG上清液中分离AT III,血浆与凝胶的比例为45体积血浆或80体积10%Fr.IV-1溶液比1体积凝胶;(c)在Pellicon超滤系统上对洗脱的AT III进行浓缩和脱盐;(d)在0.5M柠檬酸钠(pH 7.5)存在下于60℃加热10小时对AT III浓缩物进行巴氏消毒;(e)通过在Sephadex G-50上进行凝胶过滤去除过量的柠檬酸盐;以及(f)无菌过滤、灌装和冻干。从113升血浆批次中活性回收率为32%,从42千克Fr.IV-1批次中活性回收率为16%。源自血浆或Fr.IV-1的两种AT III浓缩物具有相似的比活性和电泳纯度,无热原性,并且符合FDA对生物制品的所有其他要求。巴氏消毒导致AT III制剂的圆盘凝胶和等速电泳图谱发生变化。

相似文献

1
Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate.大规模分级分离方法的发展。VII. 抗凝血酶III浓缩物的制备。
Vox Sang. 1979;36(5):281-93. doi: 10.1111/j.1423-0410.1979.tb04436.x.
2
A single-step method for the isolation of antithrombin III.
Vox Sang. 1984;47(6):397-405. doi: 10.1111/j.1423-0410.1984.tb03875.x.
3
A pasteurized antithrombin III concentrate for clinical use.一种临床使用的巴氏消毒抗凝血酶III浓缩物。
Vox Sang. 1985;48(6):325-32. doi: 10.1111/j.1423-0410.1985.tb00192.x.
4
A highly purified antithrombin III concentrate prepared from human plasma fraction IV-1 by affinity chromatography.
Vox Sang. 1994;67(2):117-24. doi: 10.1111/j.1423-0410.1994.tb01645.x.
5
Purification and large-scale preparation of antithrombin III.
Am J Med. 1989 Sep 11;87(3B):23S-26S. doi: 10.1016/0002-9343(89)80527-3.
6
Pasteurisation induced changes in an antithrombin III concentrate.巴氏杀菌对一种抗凝血酶III浓缩物的影响。
Thromb Res. 1986 Jul 15;43(2):219-27. doi: 10.1016/0049-3848(86)90063-0.
7
In vitro characterization of antithrombin III concentrates--a single-blind study.
Haemostasis. 1995 Jul-Aug;25(4):193-201. doi: 10.1159/000217160.
8
Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
Bioseparation. 1994 Dec;4(6):369-81.
9
Heparin cofactor II: purification and antibody production.
Thromb Haemost. 1986 Feb 28;55(1):19-23.
10
Development of large-scale fractionation methods. VI. An improved method for preparation of antihemophilic factor.大规模分级分离方法的发展。VI. 一种制备抗血友病因子的改进方法。
Vox Sang. 1978 Jul-Aug;35(1-2):18-31. doi: 10.1111/j.1423-0410.1978.tb02896.x.

引用本文的文献

1
Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency.遗传性抗凝血酶缺陷症患者妊娠时的静脉血栓栓塞症预防和治疗。
Int J Womens Health. 2013 May 3;5:233-41. doi: 10.2147/IJWH.S43190. Print 2013.
2
Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.肝素增强的纤溶酶-抗凝血酶III反应的动力学分析。肝素的表观催化作用。
Biochem J. 1981 Dec 1;199(3):521-6. doi: 10.1042/bj1990521.
3
Interaction of plasmin with endothelial cells.
纤溶酶与内皮细胞的相互作用。
Biochem J. 1984 Feb 15;218(1):119-24. doi: 10.1042/bj2180119.